Related Articles
Variant allele frequency changes in TP53 predict pembrolizumab response in patients with metastatic urothelial carcinoma
Differences in actionable genomic alterations between brain metastases and non‑brain metastases in patients with non‑small cell lung cancer
Targeted treatments after chemoradiotherapy failure in a patient with relapsed, advanced non‑small cell lung cancer with on‑therapy circulating tumor biomarker monitoring: A case report
Sequencing of circulating tumor DNA for dynamic monitoring of gene mutations in advanced non-small cell lung cancer
Changes in the gene mutation profiles of circulating tumor DNA detected using CAPP‑Seq in neoadjuvant chemotherapy‑treated advanced ovarian cancer